List of Tables
Table 1. Cancers Immunotherapy Drugs Market Trends
Table 2. Cancers Immunotherapy Drugs Market Drivers & Opportunity
Table 3. Cancers Immunotherapy Drugs Market Challenges
Table 4. Cancers Immunotherapy Drugs Market Restraints
Table 5. Global Cancers Immunotherapy Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Cancers Immunotherapy Drugs Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Cancers Immunotherapy Drugs Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Cancers Immunotherapy Drugs Product Type
Table 9. Key Companies Time to Begin Mass Production of Cancers Immunotherapy Drugs
Table 10. Global Cancers Immunotherapy Drugs Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancers Immunotherapy Drugs as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Cancers Immunotherapy Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Cancers Immunotherapy Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Cancers Immunotherapy Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Cancers Immunotherapy Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Cancers Immunotherapy Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Cancers Immunotherapy Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Cancers Immunotherapy Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Cancers Immunotherapy Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Cancers Immunotherapy Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Cancers Immunotherapy Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Cancers Immunotherapy Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Cancers Immunotherapy Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Cancers Immunotherapy Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Cancers Immunotherapy Drugs Sales Value by Region (2019-2024) & (%)
Table 27. Global Cancers Immunotherapy Drugs Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Cancers Immunotherapy Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Cancers Immunotherapy Drugs Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Cancers Immunotherapy Drugs Sales Value, (2025-2030) & (US$ Million)
Table 31. Roche Basic Information List
Table 32. Roche Description and Business Overview
Table 33. Roche Cancers Immunotherapy Drugs Products, Services and Solutions
Table 34. Revenue (US$ Million) in Cancers Immunotherapy Drugs Business of Roche (2019-2024)
Table 35. Roche Recent Developments
Table 36. Pfizer Basic Information List
Table 37. Pfizer Description and Business Overview
Table 38. Pfizer Cancers Immunotherapy Drugs Products, Services and Solutions
Table 39. Revenue (US$ Million) in Cancers Immunotherapy Drugs Business of Pfizer (2019-2024)
Table 40. Pfizer Recent Developments
Table 41. Merck Basic Information List
Table 42. Merck Description and Business Overview
Table 43. Merck Cancers Immunotherapy Drugs Products, Services and Solutions
Table 44. Revenue (US$ Million) in Cancers Immunotherapy Drugs Business of Merck (2019-2024)
Table 45. Merck Recent Developments
Table 46. Novartis Basic Information List
Table 47. Novartis Description and Business Overview
Table 48. Novartis Cancers Immunotherapy Drugs Products, Services and Solutions
Table 49. Revenue (US$ Million) in Cancers Immunotherapy Drugs Business of Novartis (2019-2024)
Table 50. Novartis Recent Developments
Table 51. Johnson & Johnson Basic Information List
Table 52. Johnson & Johnson Description and Business Overview
Table 53. Johnson & Johnson Cancers Immunotherapy Drugs Products, Services and Solutions
Table 54. Revenue (US$ Million) in Cancers Immunotherapy Drugs Business of Johnson & Johnson (2019-2024)
Table 55. Johnson & Johnson Recent Developments
Table 56. Sanofi Basic Information List
Table 57. Sanofi Description and Business Overview
Table 58. Sanofi Cancers Immunotherapy Drugs Products, Services and Solutions
Table 59. Revenue (US$ Million) in Cancers Immunotherapy Drugs Business of Sanofi (2019-2024)
Table 60. Sanofi Recent Developments
Table 61. GlaxoSmithKline Basic Information List
Table 62. GlaxoSmithKline Description and Business Overview
Table 63. GlaxoSmithKline Cancers Immunotherapy Drugs Products, Services and Solutions
Table 64. Revenue (US$ Million) in Cancers Immunotherapy Drugs Business of GlaxoSmithKline (2019-2024)
Table 65. GlaxoSmithKline Recent Developments
Table 66. Amgen Basic Information List
Table 67. Amgen Description and Business Overview
Table 68. Amgen Cancers Immunotherapy Drugs Products, Services and Solutions
Table 69. Revenue (US$ Million) in Cancers Immunotherapy Drugs Business of Amgen (2019-2024)
Table 70. Amgen Recent Developments
Table 71. AbbVie Basic Information List
Table 72. AbbVie Description and Business Overview
Table 73. AbbVie Cancers Immunotherapy Drugs Products, Services and Solutions
Table 74. Revenue (US$ Million) in Cancers Immunotherapy Drugs Business of AbbVie (2019-2024)
Table 75. AbbVie Recent Developments
Table 76. Boehringer Ingelheim Basic Information List
Table 77. Boehringer Ingelheim Description and Business Overview
Table 78. Boehringer Ingelheim Cancers Immunotherapy Drugs Products, Services and Solutions
Table 79. Revenue (US$ Million) in Cancers Immunotherapy Drugs Business of Boehringer Ingelheim (2019-2024)
Table 80. Boehringer Ingelheim Recent Developments
Table 81. AstraZeneca Basic Information List
Table 82. AstraZeneca Description and Business Overview
Table 83. AstraZeneca Cancers Immunotherapy Drugs Products, Services and Solutions
Table 84. Revenue (US$ Million) in Cancers Immunotherapy Drugs Business of AstraZeneca (2019-2024)
Table 85. AstraZeneca Recent Developments
Table 86. Immatics Biotechnologies Basic Information List
Table 87. Immatics Biotechnologies Description and Business Overview
Table 88. Immatics Biotechnologies Cancers Immunotherapy Drugs Products, Services and Solutions
Table 89. Revenue (US$ Million) in Cancers Immunotherapy Drugs Business of Immatics Biotechnologies (2019-2024)
Table 90. Immatics Biotechnologies Recent Developments
Table 91. Key Raw Materials Lists
Table 92. Raw Materials Key Suppliers Lists
Table 93. Cancers Immunotherapy Drugs Downstream Customers
Table 94. Cancers Immunotherapy Drugs Distributors List
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Cancers Immunotherapy Drugs Product Picture
Figure 2. Global Cancers Immunotherapy Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Cancers Immunotherapy Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Cancers Immunotherapy Drugs Report Years Considered
Figure 5. Global Cancers Immunotherapy Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Cancers Immunotherapy Drugs Revenue in 2023
Figure 7. Cancers Immunotherapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Monoclonal Antibodies Picture
Figure 9. Check Point Inhibitors Picture
Figure 10. Interferons Picture
Figure 11. Interleukins Picture
Figure 12. Global Cancers Immunotherapy Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Cancers Immunotherapy Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Lung Cancer
Figure 15. Product Picture of Liver Cancer
Figure 16. Product Picture of Colorectal Cancer
Figure 17. Product Picture of Pancreatic Cancer
Figure 18. Product Picture of Breast Cancer
Figure 19. Product Picture of Other Cancers
Figure 20. Global Cancers Immunotherapy Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Cancers Immunotherapy Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 22. North America Cancers Immunotherapy Drugs Sales Value (2019-2030) & (US$ Million)
Figure 23. North America Cancers Immunotherapy Drugs Sales Value by Country (%), 2023 VS 2030
Figure 24. Europe Cancers Immunotherapy Drugs Sales Value (2019-2030) & (US$ Million)
Figure 25. Europe Cancers Immunotherapy Drugs Sales Value by Country (%), 2023 VS 2030
Figure 26. Asia Pacific Cancers Immunotherapy Drugs Sales Value (2019-2030) & (US$ Million)
Figure 27. Asia Pacific Cancers Immunotherapy Drugs Sales Value by Country (%), 2023 VS 2030
Figure 28. South America Cancers Immunotherapy Drugs Sales Value (2019-2030) & (US$ Million)
Figure 29. South America Cancers Immunotherapy Drugs Sales Value by Country (%), 2023 VS 2030
Figure 30. Middle East & Africa Cancers Immunotherapy Drugs Sales Value (2019-2030) & (US$ Million)
Figure 31. Middle East & Africa Cancers Immunotherapy Drugs Sales Value by Country (%), 2023 VS 2030
Figure 32. Key Countries/Regions Cancers Immunotherapy Drugs Sales Value (%), (2019-2030)
Figure 33. United States Cancers Immunotherapy Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 34. United States Cancers Immunotherapy Drugs Sales Value by Type (%), 2023 VS 2030
Figure 35. United States Cancers Immunotherapy Drugs Sales Value by Application (%), 2023 VS 2030
Figure 36. Europe Cancers Immunotherapy Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 37. Europe Cancers Immunotherapy Drugs Sales Value by Type (%), 2023 VS 2030
Figure 38. Europe Cancers Immunotherapy Drugs Sales Value by Application (%), 2023 VS 2030
Figure 39. China Cancers Immunotherapy Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 40. China Cancers Immunotherapy Drugs Sales Value by Type (%), 2023 VS 2030
Figure 41. China Cancers Immunotherapy Drugs Sales Value by Application (%), 2023 VS 2030
Figure 42. Japan Cancers Immunotherapy Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 43. Japan Cancers Immunotherapy Drugs Sales Value by Type (%), 2023 VS 2030
Figure 44. Japan Cancers Immunotherapy Drugs Sales Value by Application (%), 2023 VS 2030
Figure 45. South Korea Cancers Immunotherapy Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 46. South Korea Cancers Immunotherapy Drugs Sales Value by Type (%), 2023 VS 2030
Figure 47. South Korea Cancers Immunotherapy Drugs Sales Value by Application (%), 2023 VS 2030
Figure 48. Southeast Asia Cancers Immunotherapy Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 49. Southeast Asia Cancers Immunotherapy Drugs Sales Value by Type (%), 2023 VS 2030
Figure 50. Southeast Asia Cancers Immunotherapy Drugs Sales Value by Application (%), 2023 VS 2030
Figure 51. India Cancers Immunotherapy Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 52. India Cancers Immunotherapy Drugs Sales Value by Type (%), 2023 VS 2030
Figure 53. India Cancers Immunotherapy Drugs Sales Value by Application (%), 2023 VS 2030
Figure 54. Cancers Immunotherapy Drugs Industrial Chain
Figure 55. Cancers Immunotherapy Drugs Manufacturing Cost Structure
Figure 56. Channels of Distribution (Direct Sales, and Distribution)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
